FDA scolds Chinese firm for data integrity lapses, MIT for BIMO violations
Regulatory NewsJoanne S. Eglovitch
CDERClinical outcome assessmentClinical TrialsComplianceGMPPharmaceuticalsQuality Assurance and ControlUnited StatesWarning lettersRegulatory NewsJoanne S. EglovitchCDERClinical outcome assessmentClinical TrialsComplianceGMPPharmaceuticalsQuality Assurance and ControlUnited StatesWarning letters